Dallas, TX -- (SBWIRE) -- 06/27/2011 -- GBI Research's research, “Lifesciences IT - 2011 Yearbook provides key data, information and analysis on Lifesciences \IT that is being implemented by pharmaceutical companies. GBI Research expects that information technology (IT) in the lifesciences industry will become a trendsetter, helping pharmaceutical companies mitigate current and evolving industry challenges. IT solutions utilized in the value chain of pharmaceutical companies help them to operate effectively and efficiently. GBI expects an increase in the adoption of IT by pharmaceutical companies looking to remain competitive in the market place.

The Lifesciences industry is pressurized by various challenges such as declining Return on Investment (ROI) on R&D investments, entry of generics and layoffs. These factors are responsible for the lifesciences companies to invest in information technology solutions. Pharmaceutical companies have found that experimental techniques are costly, time-consuming, and involve the use of large numbers of animals for testing and are adapting to computerized combinatorial chemistry applications. Pharmaceutical Companies are increasingly adopting e-clinical trial solutions in the drug development phase.

Cutting down clinical trial cost is the driving motivation for the adoption of e-clinical trial solutions. Services offered by IT companies in clinical data management are costly but have been proved to save cost for the companies in the long run. CTMS and EDC will attract the highest investments in the future followed by data mining, electronic submission tools and RFID. Outsourcing helps a pharmaceutical company to reduce costs by 30-35% and this is one of the main reasons why pharmaceutical companies outsource non-core R&D operational work to IT companies. When selecting a country to outsource clinical data management work, building the required competencies to tackle client requirements has gained a higher importance than the cost advantage it provides. The predictive analytics helps a company view beyond the sales volume in to real time prescribing patterns, as a behavior of continuum.

This also helps the company to follow the evolving niche buster model. Many pharmaceutical companies have increased satisfaction levels from their customers in 2008. In 2004, 50% of the physicians were satisfied on the current number of calls. However, satisfaction levels have increased in 2008 with more than 57% of the physicians in the US satisfied with the current number of calls. The increase in satisfaction levels was directly proportional to the decrease of sales force in the US.

It is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by GBI Research’s team of industry experts.

Scope
The scope of this report includes -
Analysis of the leading segments in the Lifesciences IT market
Key drivers and barriers that have a significant impact on the Lifesciences IT market.
Competitive benchmarking of leading companies in the market.
Key M&A activities and strategic partnership deals that have taken place in 2009.
Inputs for customized IT solution based on business situation.

Reasons to buy
The report will enhance your decision making capability. It will provide you with -
Align your product portfolio to the markets with high growth potential.
Develop market-entry and market expansion strategies by identifying the leading segments poised for strong growth.
Device better strategies through the understanding of key drivers and barriers in the market.
Develop key strategic initiatives by understanding the key focus of leading companies.
Accelerate and strengthen your market position by identifying key companies for mergers, acquisitions and strategic partnerships.

Buy Now: Lifesciences IT Market
http://www.reportsnreports.com/reports/83535-lifesciences-it-2011-yearbook.html

Browse All: GBI Research Market Research Reports
http://www.reportsnreports.com/publisher/gbi-research/

Related Reports:
Specialty Pharmaceutical Industry - 2011 Yearbook
http://www.reportsnreports.com/reports/83536-specialty-pharmaceutical-industry-2011-yearbook.html

Risk Evaluation and Mitigation Strategy (REMS) - Opioids, Erythropoesis-Stimulating Agents and Cancer Therapeutics are the Most Important Classes That Require REMS
http://www.reportsnreports.com/reports/83537-risk-evaluation-and-mitigation-strategy-rems-opioids-erythro.html

Smartphone Integrated Circuits (IC) Market to 2020 - Greater Appetite for Connectivity ICs Including Wi-Fi, Bluetooth and GPS will Increase Demand
http://www.reportsnreports.com/reports/83543-smartphone-integrated-circuits-ic-market-to-2020-greater-appe.html

Innovations in Protein Kinase Therapies - Significant Proportion of Protein Kinase Pipeline Contains Small Molecule Drugs That Target Oncology
http://www.reportsnreports.com/reports/83540-innovations-in-protein-kinase-therapies-significant-proportion-.html

Technology Transfer Strategies - A Guide to Maximizing Returns Within the Pharmaceutical and Biopharmaceutical Industries
http://www.reportsnreports.com/reports/83541-technology-transfer-strategies-a-guide-to-maximizing-returns-wi.html

About ReportsnReports
ReportsnReports is an online library of over 75,000 market research reports and in-depth market research studies & analysis of over 5000 micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.

Contact:
Mr.Priyank
7557 Rambler road,
Suite727,Dallas,TX75231
Tel: +1-888-989-8004
E-mail: sales@reportsnreports.com
Website: http://www.reportsnreports.com